Iambic Therapeutics
Surveying great inventors and businesses
Axial: https://linktr.ee/axialxyz
Axial partners with great founders and inventors. We invest in early-stage life sciences companies such as Appia Bio, Seranova Bio, Delix Therapeutics, Simcha Therapeutics, among others often when they are no more than an idea. We are fanatical about helping the rare inventor who is compelled to build their own enduring business. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company. We are excited to be in business with you — email us at info@axialvc.com
Iambic Therapeutics, previously known as Entos is a drug discovery company that uses physics-based AI algorithms and high-throughput experimentation to optimize drug candidates and profiles. Using its platform, built on 4 technologies, to explore chemical space to hone in on mechanisms of action and generate diverse, high-quality leads.
Founded in 2019, the company is now building a pipeline of first-in-class and best-in-class programs. Key programs include HER2, CDK2/4 inhibitors along with newer targets. Focusing on two candidates to bring into the clinic: IAM-H1, a highly selective and brain-penetrant inhibitor of HER2 and its oncogenic mutants, and IAM-C1, a potential first-in-class selective dual CDK2/4 inhibitor. To solve treatment resistance in cell-cycle driven cancers and expand the therapeutic window for patients.
